Top compounds associated with response to MTRF1L

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	YM-155	CTRPv2	pan-cancer	AAC	0.12	0.002
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.12	0.003
mRNA	tanespimycin:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.098	0.003
mRNA	clofarabine	CTRPv2	pan-cancer	AAC	0.084	0.005
mRNA	Erlotinib	CCLE	pan-cancer	AAC	-0.12	0.007
mRNA	VER-155008	CTRPv2	pan-cancer	AAC	0.1	0.007
mRNA	Obatoclax Mesylate	CTRPv2	pan-cancer	AAC	0.093	0.007
mRNA	paclitaxel	CCLE	pan-cancer	AAC	0.12	0.007
mRNA	triazolothiadiazine	CTRPv2	pan-cancer	AAC	0.082	0.008
mRNA	CIL41	CTRPv2	pan-cancer	AAC	0.14	0.009

Download CSV